Esperion future data On ldl cholesterol treatment's potential To cut Cardiovascular risk Fails To provoke investors - Yahoo Finance

[unable to retrieve full-text content]
  • Esperion long term data On ldl cholesterol medicine's capability To cut Cardiovascular chance Fails To provoke traders  Yahoo Finance
  • Can't take statins? New pill cuts cholesterol, coronary heart assaults
  • right here's a new medication that may also address statin intolerance  13News Now
  • With heart assault data in its favor, what's subsequent for Esperion? - STAT  STAT
  • Esperion Ther apeutics stock slumps 22% premarket as records from study of cholesterol-reducing drug fail to impress investors  MarketWatch
  • View Full coverage on Google news
  • 0/Post a Comment/Comments